Net profit of Piramal Pharma rose 1.53% to Rs 277.27 crore in the quarter ended March 2025 as against Rs 273.08 crore during the previous quarter ended March 2024. Sales rose 10.78% to Rs 1689.80 crore in the quarter ended March 2025 as against Rs 1525.30 crore during the previous quarter ended March 2024.
For the full year,net profit rose 76.73% to Rs 691.40 crore in the year ended March 2025 as against Rs 391.22 crore during the previous year ended March 2024. Sales rose 20.40% to Rs 5285.71 crore in the year ended March 2025 as against Rs 4390.11 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 1689.80 | 1525.30 | 11 | 5285.71 | 4390.11 | 20 |
| OPM % | 24.65 | 25.55 | - | 19.68 | 14.08 | - |
| PBDT | 425.53 | 415.17 | 2 | 1133.23 | 712.88 | 59 |
| PBT | 364.36 | 362.67 | 0 | 911.14 | 507.62 | 79 |
| NP | 277.27 | 273.08 | 2 | 691.40 | 391.22 | 77 |